Key Points
- Insider sale: Revvity insider Maxwell Krakowiak sold 1,631 shares for approximately $235,728, reducing his ownership by 9.94% to 14,781 shares.
- Quarterly performance: Revvity reported adjusted earnings of $1.41 per share, exceeding estimates by $0.20, while revenue of $729.69 million also topped forecasts but declined 1.3% year over year.
- Analyst outlook: The stock has a consensus “Hold” rating, with a $116.57 average price target versus its reported trading price of $142.23; the company also announced a quarterly dividend of $0.07 per share.
Revvity Inc. (NYSE:RVTY - Get Free Report) insider Maxwell Krakowiak sold 1,631 shares of the business's stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $144.53, for a total value of $235,728.43. Following the completion of the sale, the insider owned 14,781 shares of the company's stock, valued at $2,136,297.93. This trade represents a 9.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Revvity Trading Down 0.8%
Shares of NYSE:RVTY opened at $142.23 on Thursday. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $149.52. The firm has a market capitalization of $15.87 billion, a price-to-earnings ratio of 67.73, a price-to-earnings-growth ratio of 2.61 and a beta of 1.09. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. The business's 50 day moving average price is $122.53 and its 200-day moving average price is $105.76.
Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping the consensus estimate of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The company had revenue of $729.69 million during the quarter, compared to analyst estimates of $702.96 million. During the same quarter in the previous year, the firm earned $1.18 EPS. The firm's revenue was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, equities research analysts forecast that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.
Revvity Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity's payout ratio is presently 13.33%.
Analysts Set New Price Targets
A number of brokerages have weighed in on RVTY. Wall Street Zen lowered Revvity from a "buy" rating to a "hold" rating in a report on Sunday, August 16th. Weiss Ratings raised shares of Revvity from a "sell (d+)" rating to a "hold (c-)" rating in a report on Thursday, July 30th. Sanford C. Bernstein initiated coverage on shares of Revvity in a research report on Friday, June 26th. They issued a "market perform" rating and a $115.00 target price for the company. UBS Group began coverage on shares of Revvity in a research note on Wednesday, September 9th. They issued a "neutral" rating and a $140.00 price target on the stock. Finally, Royal Bank Of Canada started coverage on shares of Revvity in a research report on Tuesday, September 1st. They set a "sector perform" rating and a $135.00 price target on the stock. Four investment analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company. According to data from MarketBeat.com, Revvity currently has a consensus rating of "Hold" and a consensus target price of $116.57.
Read Our Latest Stock Report on RVTY
Institutional Trading of Revvity
Hedge funds and other institutional investors have recently modified their holdings of the business. Jupiter Topco LLC acquired a new position in Revvity in the 2nd quarter valued at about $961,017,000. BlackRock Inc. acquired a new position in shares of Revvity in the second quarter valued at approximately $852,070,000. Janus Henderson Group PLC increased its stake in Revvity by 7.0% during the 4th quarter. Janus Henderson Group PLC now owns 8,161,171 shares of the company's stock worth $789,595,000 after buying an additional 533,912 shares during the period. EdgePoint Investment Group Inc. lifted its holdings in Revvity by 3.1% during the 1st quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company's stock worth $771,044,000 after buying an additional 265,204 shares in the last quarter. Finally, State Street Corp boosted its position in Revvity by 0.8% in the 2nd quarter. State Street Corp now owns 4,342,739 shares of the company's stock valued at $483,173,000 after buying an additional 32,426 shares during the period. 86.65% of the stock is owned by institutional investors and hedge funds.
About Revvity
(
Get Free Report)
Revvity, Inc is a life sciences and diagnostics company that provides technologies, products and services used by researchers, healthcare professionals and laboratories. Its offerings support applications across genomics, proteomics, cellular analysis, drug discovery, disease research and laboratory testing.
The company develops and supplies scientific instruments, reagents, consumables, software and workflow solutions. Its portfolio includes platforms for genetic and molecular analysis, imaging, high-throughput screening, biomarker research and single-cell analysis, as well as laboratory solutions used in areas such as reproductive health and newborn screening.
Revvity was established in 2023 following the separation of PerkinElmer's Applied, Food and Enterprise Services businesses from its Precision Diagnostics operations.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
